Dr. Farid Menaa (Bsc. BioEngineering ; Bsc. Biology and Physiology ; Msc. Genetics ; Master Gerontology/Geriatrics ; PhD
Radiation Oncology/Gerontology (Paris, France, 2003) ; three international post-doctoral terms in Oncology, Dermatology,
Stem cells, Hematology, Genomics ; MBA Entrepreneurship and MD candidate), is an experienced and skilled inter- and
multi-disciplinary professional. During his career, Dr. Menaa followed complementary formations in Marine Biology (Caen,
France), Pharmacy (Liege, Belgium), Biochemistry, Chemistry and Biophysics (California, USA), Business Development and
Management (USA and Brazil).
Professor, Principal Investigator, Executive Director, Consulting Healthcare and Biosystems Expert, Companys’ Advisor and
Coach, Supervisor, Editor, Editor-in-Chief, Reviewer, Event Organizer, Entrepreneur and Polyglot, Dr. Menaa earned his
degrees with high distinctions from prestigious universities and institutions worldwide. Dr. Menaa has more than 10 years
experiences either in the academic (mainly institutions from France, USA, Germany, Brazil) or in the industrial sectors such
as Guerbet SA, SANOFI, Fluorotronics, Inc.
During his ongoing career, Dr. Menaa has mainly contributed to the identification and function of new human genes
modulated by radiation ; Discovered a new signaling pathway after DNA damage ; Pointed out the link between the
presence of stem cells, some of their genetic mutations, and the patient’s diagnosis and prognostic ; Identified genomic
alterations in adult sickle cell anemia patients with stroke ; Developed new phytotherapeutic formulations against skin
conditions ; Demonstrated the importance of various natural medicines in the prevention and/or treatment of diverse
inflammatory-state and non-communicable diseases (NCDs) ; Contributed to the development and characterization of new
nanomaterials ; Developped personalized translational medical strategies to diagnose and treat better and faster chronic
pathologies.
In 2009, Dr. Menaa was named Chief Scientific Officer (CSO) and R&D&I Executive Vice-Pressident (EVP) for Fluorotronics,
Inc, CA, USA, the leading company in Fluorine-Carbon Spectroscopy. Dr. Menaa co-developped and applied this innovative green technology to Nanomedicine, Medicinal Chemistry, Nanotechnology, Oncology, Pharmaceutical and Life Sciences.